以色列rehovot，2020年10月13日 - 新星（納斯達克：NVMI），在半導體製造中使用的高級流程控製方案領域的領導者，今天宣布打算以市場狀況和其他因素提供提供的意圖，1.5億美元的總計可轉換高級票據的總額為2025年的2025年（“票據”）根據1933年的《證券法》（《證券法》），根據規則144A向合格機構買家提供（“奉獻”）。與發行有關，Nova希望授予票據的初始購買者購買的選擇，以在開始的13天期間和包括票據首次發行的日期，最高可額外22.5美元。票據的總本金。

票據的最終條款，包括初始轉換價格，利率和某些其他條款，將在產品定價時確定。發行時，票據將是NOVA的高級，無抵押義務。票據的利息將在欠款中每半年付款，票據將於2025年10月15日成熟，除非較早在此日期之前根據其條款回購，兌換或轉換。在2025年7月15日之前的工作日結束之前，隻有在某些條件和一定時期內滿足票據的持有人的選擇，票據將可轉換。此後，票據將隨時可轉換，直到在到期日之前的第二個預定交易日收盤時。The Notes will be convertible into cash, ordinary shares of Nova or a combination thereof, with the form of consideration determined at Nova’s election.

除非發生某些稅法變更，否則NOVA可能不會在2023年10月20日之前兌換票據。在2023年10月20日或之後，Nova可能會兌換現金，全部或部分票據，如果其普通股的最後一次報告的銷售價格至少是轉換價格的130％，那麼至少有效期為20個交易日（無論是否連續）在連續30個交易日期間（包括此期間的最後交易日）結束，並在Nova在NOVA提供以兌換價格的通知之前的交易日結束，並在此期間結束。要贖回的票據的本金的100％，以及應計和無償的權益，但不包括贖回日期。票據的持有人將有權要求Nova以現金回購價格等於本金的100％的現金價格，以進行基本變更（按照票據的契約中定義）進行全部或一部分票據。在要回購的票據中，加上任何應計和無償的權益，但不包括基本變更回購日期。

諾瓦intends to use up to approximately $20.0 million of the net proceeds from the Offering to repurchase Nova’s ordinary shares from certain purchasers of the Notes in privately negotiated transactions effected through one or more of the initial purchasers of the Notes or an affiliate thereof concurrently with the pricing of the Offering, which could increase (or reduce the size of any decrease) in the market price of Nova’s ordinary shares prior to, concurrently with, or shortly after the pricing of the Notes, and could result in a higher effective conversion price for the Notes. Nova may also use a portion of the net proceeds to acquire complementary businesses, products, services or technologies. However, Nova has not entered into any agreements for or otherwise committed to any specific acquisitions at this time. Nova intends to use any remaining net proceeds from the Offering for general corporate purposes. If the initial purchasers exercise their option to purchase additional Notes, Nova expects to use the net proceeds from the sale of the additional Notes for general corporate purposes.

票據將僅提供給根據《證券法》規則144A合理地被認為是合理的機構買家的人。票據的要約和銷售是在票據轉換後（如果有的話）可能發行的NOVA的普通股，並且不會根據《證券法》，任何其他任何其他任何其他國家證券法或證券法注冊管轄權，除非這樣注冊，否則在美國不得在美國提供或出售此類票據以及此類股份（如果有的話），除非適用於此類注冊要求的豁免。

本新聞稿不新万博哪儿下载構成出售或征求購買要約的要約，也不構成任何州或管轄權的票據（或票據轉換後可發行的Nova的任何普通股）的要約或出售在任何此類州或管轄權的證券法律的注冊或資格之前，要約，招標或出售將是非法的。

關於Nova：

Nova是用於半導體製造中使用的高級過程控製的指標解決方案的主要創新者和關鍵提供商。NOVA通過提供最先進的高性能計量解決方案來提供持續的創新，以在整個半導體製造生命周期內進行有效的過程控製。Nova的產品組合結合了高精度硬件和尖端軟件，為客戶提供了深入了解最先進的半導體設備的開發和生產。Nova提供創新的X射線和光學解決方案的獨特能力，使其客戶能夠提高性能，提高產品產量並加速市場上的時間。Nova是來自世界各地辦事處的半導體製造商的合作夥伴。

Nova在符號NVMI下的NASDAQ上和符號下的Tase交易נבב。

前瞻性語句

本新聞稿包新万博哪儿下载含1995年《私人證券訴訟改革法案法案》的安全港規定的含義，與未來事件或我們的未來績效有關，例如關於但不限於Nova提供和發行的陳述the Notes and the terms of the Notes, the anticipated use of proceeds from the Offering, whether Nova will repurchase any of its ordinary shares concurrently with the pricing of the Notes and any related effects on the trading price of Nova’s ordinary shares prior to, concurrently with, or shortly after the pricing of the Notes, and the conversion price of the Notes. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: our dependency on three product lines; our dependency on a small number of large customers and small number of suppliers; the highly cyclical and competitive nature of the markets we target and we operate in; our inability to reduce spending during a slowdown in the semiconductor industry; our ability to respond effectively on a timely basis to rapid technological changes; our dependency on PEMs; risks related to exclusivity obligations and non-limited liability that may be included in our commercial agreements and arrangements; our ability to retain our competitive position despite the ongoing consolidation in our industry; risks related to our dependence on our manufacturing facilities; risks related to changes in our order backlog; risks related to efforts to complete and integrate current and/or future acquisitions; risks related to worldwide financial and economic instabilities, including the implications of the ongoing novel coronavirus (COVID-19) pandemic; risks related to our intellectual property; new product offerings from our competitors; unanticipated manufacturing or supply problems; risks related to government programs we participate in; risks related to taxation; changes in customer demand for our products; risks related to currency fluctuations; risks related to technology security threats, including data breaches, cyberattacks and system disruptions, and changes in privacy laws; risks related to acquisitions we may pursue and risks related to our operations in Israel. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading “Risk Factors” in Nova’s Annual Report on Form 20-F for the year ended December 31, 2019 filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2020. These factors are updated from time to time through the filing of reports and registration statements with the SEC. Nova Measuring Instruments Ltd. does not assume any obligation to update the forward-looking information contained in this press release.